Russell Frank Company’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Russell Frank Company’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.41M	Buy	362,327 +140,194	+63%	+$1.97M	0.01%	1421
2015 Q4	$3.52M	Sell	222,133 -89,118	-29%	-$1.4M	0.01%	1483
2015 Q3	$4.77M	Sell	311,251 -116,880	-27%	-$2.53M	0.01%	1296
2015 Q2	$10.4M	Buy	428,131 +44,336	+12%	+$1.06M	0.02%	954
2015 Q1	$8.92M	Buy	383,795 +52,771	+16%	+$1.4M	0.02%	932
2014 Q4	$8.3M	Buy	331,024 +138,934	+72%	+$4.08M	0.01%	982
2014 Q3	$5.97M	Buy	192,090 +96,817	+102%	+$2.62M	0.01%	1176
2014 Q2	$2.46M	Buy	95,273 +32,914	+53%	+$731K	﹤0.01%	1641
2014 Q1	$1.28M	Buy	62,359 +5,195	+9%	+$114K	﹤0.01%	1974
2013 Q4	$1.08M	Buy	57,164 +6,307	+12%	+$142K	﹤0.01%	2040
2013 Q3	$1.04M	Buy	50,857 +12,562	+33%	+$280K	﹤0.01%	2159
2013 Q2	$803K	Buy	+38,295	New	+$684K	﹤0.01%	2153

Other funds holding SGNT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Frank Company's SGNT Position: Q1 2016 in Review

Russell Frank Company increased its SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) stake by 63% in Q1 2016, buying an estimated $1.97M and bringing the position to 362,327 shares worth $4.41M. The position accounts for 0.01% of the portfolio, ranked #1421.

Russell Frank Company first reported a position in SGNT in Q2 2013 and has held it in 12 quarters since. The position peaked at $10.4M in Q2 2015. 136 funds tracked by Wall St. Rank hold SGNT as of Q1 2016.

Russell Frank Company held 362,327 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $4.41M as of Q1 2016.
Russell Frank Company bought 140,194 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016, an estimated $1.97M.
SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1421 holding.
Russell Frank Company first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $10.4M in Q2 2015.
136 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.